Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model
C R Benedict, J Ryan, B Wolitzky, R Ramos, M Gerlach, P Tijburg, D Stern, C R Benedict, J Ryan, B Wolitzky, R Ramos, M Gerlach, P Tijburg, D Stern
Abstract
To assess the contribution of Factor IX/IXa, to intravascular thrombosis, a canine coronary thrombosis model was studied. Thrombus formation was initiated by applying current to a needle in the circumflex coronary artery. When 50% occlusion of the vessel developed, the current was stopped and animals received an intravenous bolus of either saline, bovine glutamyl-glycyl-arginyl-Factor IXa (IXai), a competitive inhibitor of Factor IXa assembly into the intrinsic Factor X activation complex, bovine Factor IX, or heparin. Animals receiving saline or Factor IX developed coronary occlusion due to a fibrin/platelet thrombus in 70 +/- 11 min. In contrast, infusion of IXai prevented thrombus formation completely (greater than 180 min) at doses of 460 and 300 micrograms/kg, and partially blocked thrombus formation at 150 micrograms/kg. IXai attenuated the accumulation of 125I-fibrinogen/fibrin at the site of the thrombus by approximately 67% (P less than 0.001) and resulted in approximately 26% decrease in serotonin release from platelets in coronary sinus (P less than 0.05). Hemostatic variables in animals receiving IXai, remained within normal limits. Animals given heparin in a concentration sufficient to prevent occlusive thrombosis had markedly increased bleeding, whereas heparin levels that maintained extravascular hemostasis did not prevent intracoronary thrombosis. This suggests that Factor IX/IXa can contribute to thrombus formation, and that inhibition of IXa participation in the clotting mechanism blocks intravascular thrombosis without impairing extravascular hemostasis.
References
- Biochemistry. 1974 Oct 22;13(22):4508-16
- Biochemistry. 1973 Nov 20;12(24):4938-45
- J Biol Chem. 1977 Dec 10;252(23):8481-8
- Thromb Res. 1979;14(6):931-40
- Thromb Res. 1980 Mar 15;17(6):841-53
- Biochim Biophys Acta. 1982 Feb 25;714(3):543-8
- Blood. 1982 Dec;60(6):1353-8
- J Biol Chem. 1985 Jun 10;260(11):6717-22
- Circ Res. 1986 Jan;58(1):58-67
- Blood. 1986 Mar;67(3):565-72
- Biochem Med Metab Biol. 1987 Jun;37(3):314-22
- Br J Haematol. 1987 Jun;66(2):227-32
- Blood. 1988 Jan;71(1):1-8
- Blood. 1988 Mar;71(3):629-35
- J Biol Chem. 1989 Feb 25;264(6):3244-51
- CRC Crit Rev Biochem. 1988;23(4):339-68
- Am J Pathol. 1989 May;134(5):1087-97
- Thromb Haemost. 1989 Feb 28;61(1):101-5
- J Clin Invest. 1989 Sep;84(3):824-8
- Blood. 1990 Aug 15;76(4):731-6
- FASEB J. 1990 Oct;4(13):3087-98
- Proc Natl Acad Sci U S A. 1990 Nov;87(22):8869-73
- Proc Natl Acad Sci U S A. 1977 Jul;74(7):3028-32
Source: PubMed